Patients Beyond distance and stigma: AI's potential to democratise he... Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.
Patients Operationalising diversity through site and patient engageme... Most sponsors are aware of the benefits that may arise from increasing the diversity of clinical trial patient populations.
R&D Ensuring R&D investments deliver maximum potential: Notable ... As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.
News MSD eyes June verdict for paediatric RSV antibody The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.